These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 34313839)
21. Knockdown of DEAD-box 51 inhibits tumor growth of esophageal squamous cell carcinoma Hu DX; Sun QF; Xu L; Lu HD; Zhang F; Li ZM; Zhang MY World J Gastroenterol; 2022 Jan; 28(4):464-478. PubMed ID: 35125830 [TBL] [Abstract][Full Text] [Related]
22. Glypican-1 Promotes Tumorigenesis by Regulating the PTEN/Akt/β-Catenin Signaling Pathway in Esophageal Squamous Cell Carcinoma. Li J; Chen Y; Zhan C; Zhu J; Weng S; Dong L; Liu T; Shen X Dig Dis Sci; 2019 Jun; 64(6):1493-1502. PubMed ID: 30730015 [TBL] [Abstract][Full Text] [Related]
24. RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma. Wang L; Hou Z; Hasim A; Abuduerheman A; Zhang H; Niyaz M; Awut I; Upur H; Sheyhidin I Int J Oncol; 2018 Mar; 52(3):861-871. PubMed ID: 29393393 [TBL] [Abstract][Full Text] [Related]
25. Expression and clinical significance of REPS2 in human esophageal squamous cell carcinoma. Zhang H; Duan CJ; Zhang H; Cheng YD; Zhang CF Asian Pac J Cancer Prev; 2013; 14(5):2851-7. PubMed ID: 23803043 [TBL] [Abstract][Full Text] [Related]
26. Overexpression of GNA13 correlates with poor prognosis in esophageal squamous cell carcinoma after esophagectomy. Pan Z; Zheng Z; Ye W; Chen C; Ye S Int J Biol Markers; 2022 Sep; 37(3):289-295. PubMed ID: 35706395 [TBL] [Abstract][Full Text] [Related]
27. Overexpression of SRC-3 promotes esophageal squamous cell carcinoma aggressiveness by enhancing cell growth and invasiveness. Xu FP; Liu YH; Luo XL; Zhang F; Zhou HY; Ge Y; Liu C; Chen J; Luo DL; Yan LX; Mei P; Xu J; Zhuang HG Cancer Med; 2016 Dec; 5(12):3500-3511. PubMed ID: 27781415 [TBL] [Abstract][Full Text] [Related]
28. E2F1-activated NRSN2 promotes esophageal squamous cell carcinoma progression through AKT/mTOR pathway. Yan Z; Xu T; Lu J; Wu Z; Li X; Xu J; Guo W; Dong Z Pathol Res Pract; 2022 Aug; 236():153963. PubMed ID: 35662041 [TBL] [Abstract][Full Text] [Related]
29. [Effects of microRNA-182-5p on cell proliferation and invasion of esophageal squamous cell carcinoma and related molecular mechanisms]. Zhu ZQ; Hu HF; Zheng XY; Wang F Zhonghua Zhong Liu Za Zhi; 2020 Aug; 42(8):635-643. PubMed ID: 32867454 [No Abstract] [Full Text] [Related]
30. NOX4 overexpression is a poor prognostic factor in patients undergoing curative esophagectomy for esophageal squamous cell carcinoma. Chen YH; Lu HI; Lo CM; Hsiao CC; Li SH Surgery; 2020 Mar; 167(3):620-627. PubMed ID: 31889545 [TBL] [Abstract][Full Text] [Related]
31. Increased Numb protein expression predicts poor clinical outcomes in esophageal squamous cell carcinoma patients. Liu Z; Luo C; Yang W; Wang K; Hu C; Zou J; Zhu H; Fu L; Nie J; Cheng C Cancer Biol Ther; 2018 Jan; 19(1):34-41. PubMed ID: 28095111 [TBL] [Abstract][Full Text] [Related]
32. Significance of PI3K/AKT signaling pathway in metastasis of esophageal squamous cell carcinoma and its potential as a target for anti-metastasis therapy. Li B; Xu WW; Lam AKY; Wang Y; Hu HF; Guan XY; Qin YR; Saremi N; Tsao SW; He QY; Cheung ALM Oncotarget; 2017 Jun; 8(24):38755-38766. PubMed ID: 28418888 [TBL] [Abstract][Full Text] [Related]
33. Identification of LETM1 as a marker of cancer stem-like cells and predictor of poor prognosis in esophageal squamous cell carcinoma. Yang Z; Ni W; Cui C; Qi W; Piao L; Xuan Y Hum Pathol; 2018 Nov; 81():148-156. PubMed ID: 30031102 [TBL] [Abstract][Full Text] [Related]
34. Overexpression of U three protein 14a (UTP14a) is associated with poor prognosis of esophageal squamous cell carcinoma. Li KK; Mao CY; Zhang JG; Ma Q; Wang YJ; Liu XH; Bao T; Guo W Thorac Cancer; 2019 Nov; 10(11):2071-2080. PubMed ID: 31496055 [TBL] [Abstract][Full Text] [Related]
35. DEPTOR suppresses the progression of esophageal squamous cell carcinoma and predicts poor prognosis. Ji YM; Zhou XF; Zhang J; Zheng X; Li SB; Wei ZQ; Liu T; Cheng DL; Liu P; Song K; Tan T; Zhu H; Guo JL Oncotarget; 2016 Mar; 7(12):14188-98. PubMed ID: 26893358 [TBL] [Abstract][Full Text] [Related]
36. Analysis of SPARC and TUBB3 as predictors for prognosis in esophageal squamous cell carcinoma receiving nab-paclitaxel plus cisplatin neoadjuvant chemotherapy: a prospective study. Gong L; Mao W; Chen Q; Jiang Y; Fan Y Cancer Chemother Pharmacol; 2019 Apr; 83(4):639-647. PubMed ID: 30643929 [TBL] [Abstract][Full Text] [Related]
37. Beclin-1 is a Promising Prognostic Biomarker in a Specific Esophageal Squamous Cell Carcinoma Population. Du H; Luo F; Shi M; Che J; Zhu L; Li H; Hang J Pathol Oncol Res; 2021; 27():594724. PubMed ID: 34257544 [TBL] [Abstract][Full Text] [Related]
38. Oncogenic role of protein tyrosine kinase 7 in esophageal squamous cell carcinoma. Shin WS; Kwon J; Lee HW; Kang MC; Na HW; Lee ST; Park JH Cancer Sci; 2013 Aug; 104(8):1120-6. PubMed ID: 23663482 [TBL] [Abstract][Full Text] [Related]
39. [Prognostic influence of preoperative Nutritional Risk Screening -2002 (NRS-2002) score for patients with thoracic esophageal squamous cell carcinoma receiving surgery]. Sun HJ; Guo XW; Ji SJ; Zhou SB; Gu L Zhonghua Zhong Liu Za Zhi; 2018 Dec; 40(12):917-921. PubMed ID: 30605983 [No Abstract] [Full Text] [Related]
40. DNA Repair Protein Rad51 Induces Tumor Growth and Metastasis in Esophageal Squamous Cell Carcinoma via a p38/Akt-Dependent Pathway. Chiu WC; Fang PT; Lee YC; Wang YY; Su YH; Hu SC; Chen YK; Tsui YT; Kao YH; Huang MY; Yuan SF Ann Surg Oncol; 2020 Jun; 27(6):2090-2101. PubMed ID: 31749080 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]